Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Research Applications Key Differences BPC-157 is more associated with cell signalling and repair pathways TB-500 is more associated with cell movement and structural reorganisation Practical Considerations for Comparative Research For researchers designing comparative or combination protocols with BPC-157 and TB-500, four practical points come up repeatedly: Reconstitution both compounds are supplied lyophilised and dissolve readily in bacteriostatic water
Reconstitution and laboratory handling A 10 mg vial of Epithalon reconstituted with 2 mL of bacteriostatic water yields a final concentration of 5 mg/mL, or 5,000 mcg/mL
How long will unreconstituted peptide last
A common research protocol: BPC-157: 250500 mcg daily (subcutaneous near injury) TB-500: 2.5 mg twice weekly (subcutaneous) Duration: 48 weeks The Bottom Line Neither peptide is universally "better" they excel in different contexts and work through different mechanisms
